Introduction
The abundance of cellular proteins is tightly regulated in a coordinated manner at the levels of both their synthesis and degradation. In particular, intracellular proteolysis by the ubiquitin-proteasome system is responsible for such specific degradation of proteins. Two major classes of ubiquitin ligase, the anaphasepromoting complex (APC) or cyclosome and the Skp1-Cul1-F-box protein complex (SCF), play important roles in cell cycle progression (Nakayama and Nakayama, 2006) . F-box proteins are the determinants of substrate specificity of SCF. One member of this protein family, Fbxw7 (also known as Fbw7, SEL-10, hCdc4 or hAgo), was initially identified as a negative regulator of LIN-12 (Notch)-mediated signaling in Caenorhabditis elegans by genetic analysis (Sundaram and Greenwald, 1993; Hubbard et al., 1997) . Fbxw7 also interacts with Notch family proteins and promotes their ubiquitin-dependent turnover in mammalian cells (Hubbard et al., 1997; Gupta-Rossi et al., 2001; Oberg et al., 2001) . Furthermore, it targets for degradation in various mammalian proteins that control cell cycle progression (Nakayama and Nakayama, 2006; Welcker and Clurman, 2008) , including cyclin E (Koepp et al., 2001; Moberg et al., 2001; Strohmaier et al., 2001) , c-Myc (Welcker et al., 2004; Yada et al., 2004) and c-Jun (Nateri et al., 2004; Wei et al., 2005) . Mice that lack Fbxw7 show marked accumulation of Notch and die in utero at embryonic day (E) 10.5 manifesting vascular abnormalities caused by dysregulation of Notch signaling activity (Tetzlaff et al., 2004; Tsunematsu et al., 2004) . Abnormal accumulation of c-Myc also occurs in Fbxw7 À/À embryonic stem cells (Yada et al., 2004) . Furthermore, the threonine-58 residue of c-Myc, the phosphorylation of which is required for the binding of Fbxw7 to c-Myc, is frequently mutated in certain human malignancies. These observations suggest that Fbxw7 functions as an oncosuppressor by promoting the degradation of c-Myc (Welcker et al., 2004; Yada et al., 2004; Fujii et al., 2006) .
The Fbxw7 gene itself is also mutated in certain human cancers (Akhoondi et al., 2007; Welcker and Clurman, 2008) . Many, but not all, primary human tumors with FBXW7 mutations exhibit increased levels of cyclin E. A mouse model expressing a degradationresistant mutant of cyclin E manifests an increased susceptibility to cancer in association with deregulation of cyclin E expression (Loeb et al., 2005) . The deregulation of cyclin E expression caused by mutation of FBXW7 thus likely contributes directly to the development of at least a subset of human tumors. However, the observations that the abundance of cyclin E was not increased either in the thymic lymphomas that develop in mice with conditional ablation of Fbxw7 (Fbxw7 D/D mice) (Onoyama et al., 2007) or in the radiation-induced lymphomas that are frequently observed in Fbxw7 þ /À mice (Mao et al., 2004) suggest that Fbxw7 contributes to cyclin E proteolysis in a contextdependent manner.
Given that the substrates of Fbxw7 include key proteins that contribute to diverse biological processes, including the cell cycle, cell differentiation, and apoptosis, and that the binding of Fbxw7 to its substrates depends on their phosphorylation, the function of this protein is likely complex. Although much attention has been focused on the relation between cyclin E accumulation and tumorigenesis, Notch degradation by Fbxw7 is critical during embryogenesis, suggesting that Fbxw7 functions in development-and tissue-dependent manners. To provide insight into the physiological and pathological relevance of Fbxw7, we have now achieved conditional inactivation of Fbxw7 in mouse embryonic fibroblasts (MEFs). We here show that ablation of Fbxw7 induces cell cycle arrest and apoptosis both by eliciting the accumulation of Notch and in a manner dependent in part on p53.
Results

Reduced growth rate of Fbxw7-deficient fibroblasts
To study the physiological role of Fbxw7, we prepared Fbxw7-null primary fibroblasts (Fbxw7 D/D MEFs) from mice homozygous for a 'floxed' Fbxw7 allele (Fbxw7 F/F mice) (Onoyama et al., 2007) . Conditional inactivation of Fbxw7 was induced by infection of the primary Fbxw7
MEFs with a retrovirus encoding Cre recombinase. PCR analysis of genomic DNA showed that the floxed allele was undetectable in the infected cells (data not shown). Reverse transcription (RT) and real-time PCR analyses also revealed that the amount of Fbxw7 mRNA was reduced by about one-half in Fbxw7 þ /D MEFs (compared with that in Fbxw7 þ / þ cells) and was virtually undetectable in Fbxw7 D/D MEFs ( Figure 1a) .
The morphology of Fbxw7 þ /D MEFs was indistinguishable from that of wild-type cells, whereas that of Fbxw7 D/D MEFs was flattened and these cells detached spontaneously from the culture dish under conventional culture conditions (Figure 1b) . The rate of proliferation of Fbxw7 D/D MEFs was also markedly reduced compared with that of Fbxw7 Figure 1c ). This latter result was unexpected given that most of the known substrates of Fbxw7, including cyclin E, c-Myc and c-Jun, are promoters of cell growth. To determine the cause of this growth retardation, we examined cell cycle progression and the incidence of apoptosis. Flow cytometric analysis revealed that the reduced growth rate of Fbxw7 D/D MEFs was attributable both to inhibition of DNA synthesis ( Figure 1d ) and to an increased frequency of apoptosis ( Figure 1e) ; the latter finding was confirmed by the TUNEL assay and detection of cells with a sub-G 1 DNA content (data not shown). These data indicated that ablation of Fbxw7 in MEFs impairs cell growth by inducing cell cycle arrest and apoptosis. (Figure 2a ). The abundance of NICD3 was also moderately increased in the Fbxw7-null cells, whereas that of NICD2 was slightly decreased (Figure 2a ). NICD4 was below the limit of detection in cells of all genotypes (data not shown). Although the expression level of cyclin E or c-Myc has been shown to be increased in several cancer cell lines with FBXW7 mutations, the amounts of these two proteins, as well as that of c-Jun, did not differ between MEFs is primary, and that the increased level of NICD1 secondarily affects the transcription of Notch3 and the abundance of NICD3.
To assess the relation between the abundance of NICD1 and that of NICD2 or NICD3, we infected wildtype MEFs with retroviral vectors encoding NICD1 or NICD3, each of which binds the transcriptional repressor RBP-J and thereby activates target genes. Forced expression of NICD1 resulted in an increase in the amount of NICD3, whereas overexpression of NICD3 (at a level greater than that of the endogenous protein in Fbxw7 D/D cells) did not substantially affect the abundance of NICD1 (Figure 2c ). Overexpression of NICD1 or NICD3 reduced the amount of NICD2. These data thus suggested that an increase in the level of NICD1 results in an increase in the amount of NICD3 and a decrease in that of NICD2, consistent with previous observations (Lopez-Nieva et al., 2004; Weng et al., 2006) To evaluate the role of the proteasome in degradation of NICD1, we examined the effects of the proteasome inhibitor MG132 on the abundance of NICD1, NICD3 and c-Jun. Treatment of wild-type MEFs with MG132 induced accumulation of NICD1, whereas this inhibitor did not increase further the elevated amount of NICD1 in Fbxw7 D/D cells (Figure 2d ). In contrast, the expression of NICD3 was decreased in both Fbxw7 þ / þ and Fbxw7
MEFs in response to MG132 treatment. The abundance of both c-Jun and p53 was increased by MG132 in both Fbxw7 þ / þ and Fbxw7 D/D MEFs, confirming the activity of the inhibitor (Figure 2d ). These data thus suggested that the defect in NICD1 proteolysis in Fbxw7-deficient cells is located upstream of proteasomal degradation. To confirm that NICD1 is stabilized in Fbxw7 D/D MEFs, we examined the turnover rate of NICD proteins in a cycloheximide chase assay. Given the low abundance of endogenous NICD1 in Fbxw7 þ / þ MEFs (Figure 2a ), we infected both Fbxw7 þ / þ and Fbxw7 D/D cells with a retroviral vector encoding NICD1. The rates of degradation of both exogenous and endogenous NICD1 proteins in Fbxw7 D/D cells were markedly reduced compared with that of exogenous NICD1 in Fbxw7
MEFs, whereas the rate of degradation of endogenous NICD3 was similar in cells of the two genotypes ( Figure 2e ). These results revealed that Fbxw7 is required for normal proteolysis of NICD1, but not for that of NICD3, in MEFs.
Cell cycle arrest induced by activation of Notch signaling
Among known Fbxw7 substrates, we found that NICD1 specifically accumulates in Fbxw7-null MEFs. To determine whether NICD1 accumulation in wild-type MEFs recapitulates the overall phenotype of Fbxw7 MEFs, wild-type cells expressing exogenous NICD1 were found to detach spontaneously from the bottom of the culture dish and to exhibit a reduced rate of cell proliferation (data not shown). Flow cytometric analysis also revealed that overexpression of NICD1 blocked entry of cells into S phase of the cell cycle ( Figure 3a ) and increased the incidence of apoptotic cell death (Kato et al., 1996; Artavanis-Tsakonas et al., 1999 
, MEFs revealed that the abnormal morphology of Fbxw7
þ / þ cells was largely normalized by ablation of Rbpj (Figures 1b and 5a) . Unlike Fbxw7 (Figure 5d ). These data suggested that a reduced activity of the transcription factor E2F in Fbxw7-deficient cells and the consequent impairment of their progression into S phase were normalized by inactivation of Notch signaling. We therefore concluded that the canonical Notch-RBP-J signaling pathway is required for induction of cell cycle arrest and apoptosis in Fbxw7-deficient MEFs.
Role of p53 in the Notch-induced replication block and apoptosis in Fbxw7 D/D cells Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway (Yang et al., 2004) , and the products of the major target genes of Notch1 (Hes1, Hey1) upregulate the transactivation activity of p53 and exert a cytotoxic effect (Huang et al., . To assess the possible role of p53 in Notchinduced growth retardation in MEFs, we first examined the effect of NICD1 overexpression on the abundance of p53 in wild-type cells. Forced expression of NICD1 increased the levels of both p53 and the cyclindependent kinase (CDK) inhibitor p21 (Figure 6a) , the latter of which is the product of one of the main target genes of p53 and is responsible for p53-dependent cell cycle arrest. The expression of c-Myc was downregulated in wild-type cells overexpressing NICD1, suggesting the cell cycle arrest before S-phase entry (Figure 6a ). These results thus indicated that the p53 pathway was activated by Notch signaling in MEFs. Furthermore, the replication block induced by overexpression of NICD1 was much less pronounced in p53 À/À MEFs (33.1 vs 28.5%, Figure 6b ) than in wild-type cells (31.9 vs 14.1%, Figure 3a ). In contrast, the induction of apoptosis by forced expression of NICD1 did not appear to differ between p53 þ / þ cells (6.6 vs 13.2%, Figure 3b ) and p53 À/À cells (4.1 vs 10.1%, Figure 6c ), suggesting that NICD1 induces apoptosis irrespective of p53 status. Thus, unlike its effect in neural progenitor cells, p53 deficiency did not completely reverse the growth defect induced by Notch activation in MEFs. Rather, p53 appears to play an important role in the DNA replication block but seems to be dispensable for the induction of apoptosis in MEFs overexpressing NICD1. (Figures 1d and 7a) , whereas the increased incidence of apoptosis in Fbxw7
MEFs and
MEFs was not normalized by p53 deletion (Figures 1e  and 7b ). The CDK inhibitor p21 was expressed at similar levels in Fbxw7
MEFs, whereas p21 was not detected in Fbxw7 (Figure 7c ). We did not detect accumulation of the Fbxw7 substrates c-Myc and cyclin E in Fbxw7 (Figures 2a and 7c) . Given that the genes for c-Myc and cyclin E are transcribed only in cycling cells, it would be expected that c-Myc and cyclin E would be downregulated as a result of Notch-induced cell cycle arrest. Consistent with this notion, the abundance of c-Myc was slightly greater in Fbxw7
À/À cells, whereas the expression of cyclin E did not differ substantially between these two genotypes (Figure 7c ). Although the rate of proliferation of Fbxw7
MEFs was augmented compared with that of Fbxw7
þ / þ and wild-type MEFs, it did not completely recover to that of Fbxw7 þ / þ p53 À/À MEFs (Figure 7d ). 
Discussion
With the use of conditional knockout mice, we have shown that the tumor suppressor Fbxw7 is essential for normal cell cycle progression and survival in primary MEFs. Fbxw7 mediates the degradation of various proteins, including c-Myc, c-Jun and cyclin E, but the contribution of the proteolysis of each of these proteins to cell cycle control as well as to tumorigenesis has been largely unclear. Our results indicate that the major physiological target of Fbxw7 in MEFs is NICD1. We conclude that the cell cycle arrest and increased incidence of apoptosis observed in Fbxw7 D/D MEFs are attributable to excessive Notch signaling.
We have previously shown that abnormal accumulation of NICD1 and c-Myc and the associated overproliferation of thymocytes resulted in thymic lymphoma in mice with conditional inactivation of Fbxw7 in the T-cell lineage (Onoyama et al., 2007) .
Additional ablation of the c-Myc gene in Fbxw7
D/D T cells reversed the overproliferation phenotype. These data suggest that c-Myc is the main target of Fbxw7 and that Fbxw7 functions as a bona fide tumor suppressor in T cells. The Notch accumulation observed in Fbxw7-deficient thymocytes appeared to have little impact on thymocyte development and proliferation. These observations contrast with our present results showing impaired cell proliferation due to overaccumulation of Notch in MEFs. Fbxw7 may therefore target different substrates for degradation in different cell types, thereby regulating cell cycle progression in a cell type-specific manner.
Fbxw7 specifically recognizes phosphorylated substrates. Sequences recognized by Fbxw7 in c-Myc, c-Jun and SREBP1a or -1c are phosphorylated by glycogen synthase kinase-3b (GSK-3b), resulting in the ubiquitylation and degradation of these proteins (Welcker et al., 2004; Yada et al., 2004; Sundqvist et al., 2005; Wei et al., 2005) . NICD1 is also phosphorylated by GSK-3b. However, inhibition of endogenous GSK-3b activity does not increase but rather reduces the stability of NICD1 in mammalian cells. Furthermore, genetic studies in Drosophila have suggested that the GSK-3b homolog Shaggy might positively modulate the Notch signaling pathway (Ruel et al., 1993; Ramain et al., 2001 ). These observations indicate that phosphorylation of NICD1 by GSK-3b does not induce its recognition and degradation by Fbxw7 (Foltz et al., 2002) . A phosphodegron of Notch has been identified and found to differ slightly from the 'typical' degrons of c-Myc and cyclin E. The serine or threonine residue at position þ 4 relative to the central threonine is thus replaced with glutamic acid in the phosphodegron of Notch (O'Neil et al., 2007; Thompson et al., 2007) . The turnover of NICD1 is thought to be regulated by the cyclin C-CDK8 complex and integrin-linked kinase (Fryer et al., 2004; Mo et al., 2007) . Together, these observations suggest that the efficiency of substrate recognition by Fbxw7 is dependent on the balance of various kinase activities that are regulated in a cell type-or developmental stage-specific manner. 
Upregulation of Notch signaling in
Unexpectedly, the accumulation of Fbxw7 substrates other than NICD1, including cyclin E and c-Myc, was not observed in Fbxw7 D/D MEFs. These proteins are expressed at a low level or are absent in quiescent cells, with mitogenic stimulation resulting in marked transcriptional activation of the corresponding genes (Blackwood et al., 1992; Koff et al., 1992) . Given that excessive Notch signaling induced proliferative arrest in MEFs, it is possible that the expression of cyclin E and c-Myc is suppressed at the transcriptional level in Fbxw7 D/D MEFs and that the proliferative arrest obscures an increase in protein stability induced by the loss of Fbxw7. Consistent with this notion, the expression of c-Myc at both the mRNA and protein levels was reduced in MEFs, in which the cell cycle was arrested by overexpression of NICD1 (Figure 6a , data not shown), whereas the abundance of c-Myc was slightly increased by Fbxw7 ablation in p53 À/À cells (Figure 7c ), in which Notch-induced arrest of the cell cycle is prevented by the lack of p53. These data suggest that Notch1 is the main physiological target of Fbxw7 in MEFs.
Although excessive Notch expression is implicated in carcinogenesis of T-cell leukemia and various solid tumors in humans (Radtke and Raj, 2003) , our results suggest that Notch signaling may be tumor suppressive in certain contexts. Gain-of-function analyses indicate that Notch activation promotes cell differentiation or arrest of cell growth in keratinocytes (Rangarajan et al., 2001 ), B cells (Zweidler-McKay et al., 2005 and neural progenitor cells (Yang et al., 2004) . Inactivation of Notch1 function in mouse skin results in hyperproliferation of epidermal cells and the subsequent development of skin tumors (Nicolas et al., 2003) . Although it was reported that c-Myc is a direct Notch1 target in Notch-dependent T-cell acute lymphoblastic leukemia (Weng et al., 2006) , we did not observe the activation of c-Myc by Notch1 in MEFs. It remains unclear how the activation of Notch elicits such conflicting responses.
We have now shown that either overexpression of NICD1 or stabilization of NICD1 by ablation of Fbxw7 resulted in cell cycle arrest and apoptosis in MEFs. Notch1 was previously shown to promote the G 1 -S transition of the cell cycle by inducing the expression of Skp2 and the consequent degradation of the CDK inhibitor p27 in 3T3 mouse fibroblasts (Sarmento et al., 2005) . This previous study was performed with a mutant form of Notch1 that lacks the extracellular domain but which remains associated with the cell membrane in the absence of g-secretase activity. In this study, the NICD1, which functions in a constitutively active manner and independently of g-secretase activity, was overexpressed in MEFs. The discrepancy between the results of this previous and our present studies might thus be attributable to this difference in dependence on g-secretase activity. It might also be due to a difference in the expression level of the Notch constructs. In neuronal progenitor cells, whether Notch induces proliferation or differentiation depends on Notch abundance (Guentchev and McKay, 2006) . Regardless, our present data suggest that endogenous Notch1 stabilized by Fbxw7 deficiency is sufficient for the induction of cell cycle arrest and apoptosis.
We show here that Fbxw7 is essential for cell cycle progression and survival in MEFs, as a result of its contribution to the degradation of Notch1. Although the determinants of target specificity of Fbxw7 in different cell types remain to be identified, suppression of Fbxw7 activity appears to induce different effects in different tissues in a context-dependent manner. Further characterization of the tissue-specific roles of Fbxw7 may shed new light on cell cycle regulation, cell differentiation and oncogenesis. 
Materials and methods
Cells and viral infection
Fbxw7 þ / þ , Fbxw7
Upregulation of Notch signaling in Fbxw7
D/D MEFs Y Ishikawa et al (Onoyama et al., 2007) and were maintained as previously described (Nakayama et al., 1996) . Fbxw7
were prepared from embryos generated by breeding Fbxw7 þ /F Rbpj F/F mice (Han et al., 2002) , and
Complementary DNAs encoding Cre recombinase or mouse NICD1 or NICD3 were subcloned into the retroviral vector pMX-puro (Morita et al., 2000) . Plat-E packaging cells were transfected with the vectors with the use of FuGENE6 (Roche, Indianapolis, IN, USA), and culture supernatants containing recombinant ecotropic retroviruses were harvested. Conditional inactivation of Fbxw7 or Rbpj was performed by infection of MEFs with a retrovirus encoding Cre recombinase. Proliferating MEFs were incubated with virus-containing culture supernatants in the presence of Polybrene (2 mg/ml) for 12 h. Twenty-four hours after infection, the cells were subjected to selection in medium containing puromycin (10 mg/ml) for 72 h.
For analysis of growth rate, cells were seeded at a density of 3 Â 10 4 cells per well in six-well plates, harvested at the indicated times, and counted with a hemocytometer. The g-secretase inhibitor DAPT and MG132 were obtained from Calbiochem (San Diego, CA, USA) and PEPTIDE (Osaka, Japan), respectively.
Flow cytometry
For analysis of cell cycle profile, cells were incubated with 20 mM bromodeoxyuridine (Sigma, St Louis, MO, USA) for 90 min (Figures 1, 4 , 5 and 7) or 10 mM bromodeoxyuridine for 30 min (Figures 3 and 6 ) and were then stained with propidium iodide and fluorescein isothiocyanate-conjugated antibodies to bromodeoxyuridine (BD Pharmingen, San Diego, CA, USA). Only cells with a DNA content of 2C or 4C were counted. For detection of apoptosis, MEFs were harvested and stained with fluorescein isothiocyanate-conjugated annexin V and counterstained with propidium iodide (AnnexinV-FITC Apoptosis Detection Kit, BD Pharmingen). All analyses were performed with an Epics XL flow cytometer and EXPO32 software (Beckman Coulter, Fullerton, CA, USA).
Protein analysis
Whole cell extracts were subjected to immunoblot analysis as described (Kitagawa et al., 1999) For analysis of Notch stability, cells were exposed to cycloheximide (20 mg/ml) and harvested at the indicated times thereafter.
Other methods including quantitative RT-PCR analysis and statistical analysis are available as Supplementary Information.
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